Exhibit 99.1

LOGO

PRESS RELEASE

 

For more information, contact:

Wallace D. Ruiz, Chief Financial Officer

SRI/Surgical Express, Inc.

(813) 891-9550

  FOR IMMEDIATE RELEASE

SRI SURGICAL REPORTS RESULTS FOR

FOURTH QUARTER AND FISCAL YEAR 2007

TAMPA, FL— Monday, March 10, 2008 — SRI/Surgical Express, Inc. (SRI) (Nasdaq: STRC), a leading provider of reusable surgical device reprocessing services supporting the healthcare industry, today announced financial results for its fourth quarter and year ended December 31, 2007.

For the fourth quarter of 2007, SRI Surgical reported total revenue of $24,000,000, an increase of $159,000 over the fourth quarter of 2006. The net loss for the fourth quarter of 2007 was $1,617,000 or $0.26 per basic and diluted common share compared to a net loss for the fourth quarter of 2006 of $634,000 or $0.10 per basic and diluted common share. Revenues for the fiscal year ended December 31, 2007 were $94,200,000, compared to $93,800,000 for the fiscal year ended December 31, 2006. The net loss for the fiscal year ended December 31, 2007 was $3,193,000 or $0.50 per basic and diluted common share compared to a net loss of $1,953,000, or $0.31 per basic and diluted common share for the fiscal year ended December 31, 2006. The fourth quarter of 2007 included a charge of approximately $796,000 to increase the reserves for doubtful accounts and obsolete disposable surgical products.

Gerald Woodard, Chief Executive Officer said “Having only been on board a month, I see many opportunities for 2008. While we face challenges, our fundamentals remain strong, including a growing market, competitive products and services, and a supporting infrastructure. My focus will be effective execution, operational excellence and customer retention. I look forward to reporting our progress to our shareholders throughout the year.”

About SRI Surgical

SRI Surgical (www.srisurgical.com) provides central processing and supply chain management services to hospitals and surgery centers across the United States. SRI Surgical serves hospitals and surgery centers in 19 states from 10 reprocessing facilities, one disposable products facility, and four distribution centers located throughout the United States.

Forward-Looking Statements

The statements in this press release that are not historical, including statements regarding SRI Surgical’s beliefs, expectations, and strategies, constitute “forward looking statements” within the meaning of the federal securities laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements. Important factors that could cause the


differences are discussed in SRI Surgical’s reports on Forms 10-Q, 10-K, and 8-K that the Company periodically files with the Securities and Exchange Commission. These factors include SRI Surgical’s sales process and market acceptance of its products and services, SRI Surgical’s capital needs, its dependence on significant customers and a significant supplier, risks of a new product offering, and the competitive healthcare marketplace. SRI Surgical does not undertake to update any forward-looking statements in this press release. Copies of SRI Surgical’s SEC filings, including its annual report on Form 10-K and quarterly reports on Form 10-Q, may be obtained by contacting SRI Surgical’s investor relations department at (813) 891-9550 or at the Investors section of the SRI Surgical Website at www.srisurgical.com.

 

FOR FURTHER INFORMATION:  

Wallace Ruiz, Sr. Vice President and CFO

SRI Surgical

 
  (813) 891-9550 Ext. 3177  
  wruiz@srisurgical.com  


SRI/SURGICAL EXPRESS, INC.

Condensed Statements of Operations

(In thousands, except per share data)

(unaudited)

 

     Three Months Ended
December 31,
    Twelve Months Ended
December 31,
 
     2007     2006     2007     2006  

Revenues

   $ 23,956     $ 23,797     $ 94,201     $ 93,831  

Cost of revenues

     19,217       17,924       73,947       71,534  
                                

Gross profit

     4,739       5,873       20,254       22,297  

Distribution expenses

     1,699       1,774       6,394       6,327  

Selling and administrative expenses

     5,378       4,681       17,775       17,574  
                                

Income (loss) from operations

     (2,338 )     (582 )     (3,915 )     (1,604 )

Interest expense

     317       292       1,385       1,206  

Other income

     (92 )     —         (342 )     —    
                                

Income (loss) before income taxes

     (2,563 )     (874 )     (4,958 )     (2,810 )

Income tax expense (benefit)

     (946 )     (240 )     (1,765 )     (857 )
                                

Net income (loss)

   $ (1,617 )   $ (634 )   $ (3,193 )   $ (1,953 )
                                

Basic earnings (loss) per common share

   $ (0.26 )   $ (0.10 )   $ (0.50 )   $ (0.31 )
                                

Weighted average common shares outstanding, basic

     6,339       6,339       6,399       6,338  
                                

Diluted earnings (loss) per common share

   $ (0.26 )   $ (0.10 )   $ (0.50 )   $ (0.31 )
                                

Weighted average common shares outstanding, diluted

     6,339       6,339       6,399       6,338  
                                


SRI/SURGICAL EXPRESS, INC.

Condensed Balance Sheets

(In thousands)

(unaudited)

 

     As of
December 31,
2007
   As of
December 31,
2006

Cash and cash equivalents

   $ 656    $ 283

Accounts receivable, net

     11,613      11,390

Inventories, net

     6,159      6,715

Prepaid expenses and other assets, net

     2,847      2,641

Reusable surgical products, net

     19,416      20,954

Property, plant and equipment, net

     31,277      32,371
             

Total assets

   $ 71,968    $ 74,354
             

Notes payable to bank

   $ 2,493    $ 2,497

Accounts payable

     7,984      6,863

Accrued expenses

     5,464      4,326

Mortgage payable

     4,286      4,524

Bonds payable

     7,060      7,720

Deferred tax liability, net

     55      1,706
             

Total liabilities

     27,342      27,636

Shareholders’ equity

     44,626      46,718
             

Total liabilities and shareholders’ equity

   $ 71,968    $ 74,354